Retatrutide is a new treatment in the fight against obesity. This novel drug, categorized as a dual GLP-1 and GIP receptor agonist, exhibits promising results in investigations. By boosting these receptors, https://haseebwvga573056.blogspothub.com/35299469/setmelanotide-a-promising-new-treatment-for-obesity